Meetings

Home Research For Researchers Research Digest Meetings

Upcoming meetings and conferences that are relevant to pancreatic cancer researchers.

 

13th International Hepato-Pancreato-Biliary Association (IHPBA) World Congress
Sept. 3 – 7, 2018
Geneva, Switzerland
An outstanding scientific program that combines current evidence and state of the art technology is being organized and will provide an excellent opportunity for learning and discussion.

18th World Gastroenterologists Summit
Sept. 7 – 8, 2018
Auckland, New Zealand
The theme for this meeting is, Novel Targets and Therapies in Gastroenterology. The goals for the conference are to gather scientific researchers and professionals involved in the field of gastroenterology to explore information, ideas and scientific data and to share their experience.

Frontiers in Ras Pathobiology and Drug Discovery
Sept. 13 – 16, 2018
Stratton, VT
The overarching goal of the meeting will be to bring scientists from a variety of backgrounds, from structural biology to cancer physiology, together to focus on the problem of RAS the oncogene using state-of-the-art tools with the hope of informing efforts at drug development.

AACR Pancreatic Cancer Special Conference
Sept. 21 – 24, 2018
Boston Marriott Copley Place, Boston, MA
PanCAN and the Lustgarten Foundation are co-lead supporters for this upcoming meeting.

Big Gut Seminars: Everything You Ever Wanted To Know About the Management of Pancreatic Cysts
Sept. 28, 2018
NYU Langone Health -- Smilow Seminar Room
This conference will feature a multidisciplinary faculty of national and international leaders and an interactive format including rapid didactic presentations; areas of debate or controversy; examination and comparison of the various clinical guidelines; and panel discussion of challenging, complex patient cases.

5th NCI Pancreatic Cancer Symposium
Oct. 2 – 3, 2018
National Institutes of Health, Bethesda, MD
The purpose of the 5th NCI-Pancreatic Cancer Symposium is to provide an opportunity to bring together the leaders and young investigators including basic researchers and clinical scientists in the field from NCI/NIH and extramural community to exchange information and understand the latest advances in tumor biology, epidemiology, early detection and treatment of pancreatic cancer. The meeting will provide an exciting forum to foster collaborations and to address future challenges in advancing our commitment of improving disease outcome in patients with this recalcitrant cancer.

Pancreas Cancer Symposium: State-of-the-Art 2018 and Beyond
Nov. 30, 2018
Zuckerman Research Center, Memorial Sloan Kettering Cancer Center, New York, NY
This one-day course in conjunction with the Center for Pancreas Cancer Research at Memorial Sloan Kettering is very timely and will review the epidemiology, genomic, molecular and pathologic underpinnings of this disease along with discussing diagnostic and therapeutic approaches for localized, locally advanced and metastatic pancreas adenocarcinoma. An emphasis will be on multidisciplinary decision making and will include a case-based focus. The course will also discuss novel treatments under development and where the field is heading. This course is designed for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, nursing, advanced practice practitioners, trainees and other disciplines.

Gastrointestinal Cancers Symposium
Jan. 17 – 19, 2019
San Francisco, CA
Join colleagues from across the globe to discover and share research in treating gastrointestinal cancers. Pancreatic Cancer Action Network will have a booth in the Exhibit Hall.

 

Wage Hope With Us

Join us to double pancreatic cancer survival by 2020.





shop purple logo

Gear, apparel, accessories and more to show off your purple pride.


Shop Now 

©2018 Pancreatic Cancer Action Network. All rights reserved. Terms of Use | Privacy Policy


Pancreatic Cancer Action Network®, PanCAN®, PurpleStride®, Wage Hope®, Know Your Tumor®, Powerful Knowledge. Personal Treatment.®, Precision Promise℠ and Demand Better For Patients. For Survival.℠ are the trademarks of the Pancreatic Cancer Action Network, Inc.


The Pancreatic Cancer Action Network is registered as a 501©3 nonprofit organization. Contributions to the Pancreatic Cancer Action Network are tax-deductible to the extent permitted by law. The Pancreatic Cancer Action Network’s tax identification number is #33-0841281.